Metastatic Malignant Neoplasm in the Lung: Clinical Trials

22 trials for Metastatic Malignant Neoplasm in the Lung, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 7 recruiting, 3 active not recruiting, 2 terminated. 10 Phase 2, 8 Phase 1, 4 Not applicable, 3 Phase 3, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 210Completed 3, Recruiting 3, Terminated 2, Active not recruiting 1, Withdrawn 1
Phase 18Completed 3, Recruiting 3, Active not recruiting 1, Withdrawn 1
Not applicable4Recruiting 2, Completed 1, Not yet recruiting 1
Phase 33Active not recruiting 1, Completed 1, Recruiting 1
Early Phase 11Active not recruiting 1

Follow Metastatic Malignant Neoplasm in the Lung: new trials by email Literature Review of Metastatic Malignant Neoplasm in the Lung trials Research Report on Metastatic Malignant Neoplasm in the Lung

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Using an Artificial Intelligence Software Tool (iSeg) During Radiation Treatment Planning for Patients With Lung Tumors
Artificial Intelligence-based Intervention, Best Practice, Computed Tomography - Lung Carcinoma, Lung Non-Small Cell Carcinoma
Not applicableNot yet recruitingNorthwestern University342027-02-132026-10-27
Aerosolized Sargramostim Added to Immunotherapy for the Treatment of Patients With Metastatic Melanoma to the Lung
Aerosol Sargramostim, Biospecimen Collection, Computed Tomography - Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Neoplasm in the Lung
Phase 1WithdrawnMayo Clinic2025-10-282025-08-07
Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care
Non-Interventional Study - Lung Carcinoma, Metastatic Malignant Neoplasm in the Lung
RecruitingMayo Clinic2502024-06-242026-09-08
Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study
Computed Tomography, Magnetic Resonance Imaging, Positron Emission Tomography - Lung Carcinoma, Lung Non-Small Cell Carcinoma
Not applicableRecruitingNorthwestern University702023-11-202026-05-29
Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies
Hafnium Oxide-containing Nanoparticles NBTXR3, Radiation Therapy - Advanced Malignant Solid Neoplasm, Metastatic Malignant Neoplasm in the Liver
Phase 1 / Phase 2RecruitingM.D. Anderson Cancer Center402023-05-082026-07-30
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Biospecimen Collection, Computed Tomography, Questionnaire Administration - Metastatic Malignant Neoplasm in the Lung, Metastatic Osteosarcoma
Phase 3RecruitingChildren's Oncology Group622022-04-012026-08-25
Robotic Bronchoscopy With Cone CT and Indocyanine Green to Aid Removal of Lung Lesions in Patients With Stage I Non-small Cell Lung Cancer or Lung Metastases, REPLACING Study
Computed Tomography, Indocyanine Green Solution, Therapeutic Bronchoscopy - Lung Non-Small Cell Carcinoma, Metastatic Malignant Neoplasm in the Lung
Phase 2WithdrawnM.D. Anderson Cancer Center2022-01-262024-10-23
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
Cisplatin, Isolated Chemotherapeutic Lung Perfusion, Metastasectomy - Metastatic Bone Sarcoma, Metastatic Malignant Neoplasm in the Lung
Phase 1 / Phase 2RecruitingRoswell Park Cancer Institute992020-07-162026-08-21
Nivolumab and Ipilimumab and Stereotactic Body Radiation Therapy in Treating Patients With Salivary Gland Cancers
Nivolumab, Ipilimumab, Stereotactic Body Radiation Therapy - Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Neoplasm in the Lung
Phase 1 / Phase 2CompletedUniversity of Washington202019-01-152023-12-29
Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery
Near-Infrared Fluorescence Imaging, Panitumumab-IRDye800, Pharmacokinetic Study - Lung Carcinoma, Metastatic Malignant Neoplasm in the Lung
Phase 1 / Phase 2RecruitingStanford University302018-07-192026-10-05
Continuous Positive Airway Pressure Device or Deep Inspiration Breath Hold in Reducing Tumor Motion in Patients Undergoing Stereotactic Body Radiation Therapy for Lung Cancer
Biphasic Positive Airway Pressure, Computed Tomography, Continuous Positive Airway Pressure - Lung Carcinoma, Malignant Respiratory Tract Neoplasm
Not applicableRecruitingM.D. Anderson Cancer Center302018-03-162026-08-11
First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide
18F-αvβ6-BP - Breast Carcinoma, Colorectal Carcinoma
Early Phase 1Active not recruitingJulie L. Sutcliffe, Ph.D272016-11-012026-02-27
Liver Surgery and Chemotherapy in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery and Lung Metastases That Cannot Be Removed by Surgery
Chemotherapy, Laboratory Biomarker Analysis, Metastasectomy - Metastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Liver
Phase 2TerminatedM.D. Anderson Cancer Center292016-09-232026-02-17
Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent Osteosarcoma
Dinutuximab, Laboratory Biomarker Analysis, Pharmacological Study - Metastatic Malignant Neoplasm in the Lung, Metastatic Osteosarcoma
Phase 2CompletedNational Cancer Institute (NCI)412016-02-042023-10-26
CT Perfusion Imaging in Predicting Treatment Response in Patients With Non-small Cell Lung Cancer or Lung Metastases Treated With Stereotactic Ablative Radiation Therapy
CAPP-Seq, Isovue-200, Computed Tomography Perfusion Imaging - Malignant Lung Neoplasm, Metastatic Malignant Neoplasm in the Lung
Phase 1CompletedStanford University192016-01-192023-11-22
Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival
Stereotactic Body Radiotherapy, Surgery - Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8, Metastatic Breast Carcinoma
Phase 2 / Phase 3CompletedNRG Oncology1292014-12-242026-07-10
Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma
Cyclophosphamide, Doxorubicin, Doxorubicin Hydrochloride - Metastatic Ewing Sarcoma, Metastatic Malignant Neoplasm in the Bone
Phase 3Active not recruitingNational Cancer Institute (NCI)3122014-12-122026-10-22
Proton Beam Re-Irradiation in Thoracic Cancers
Proton Beam Radiation Therapy - Metastatic Malignant Neoplasm in the Lung, Recurrent Disease
Not applicableCompletedUniversity of Washington62014-09-092018-11-20
Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy
Doxepin Hydrochloride, Placebo, Quality-of-Life Assessment - Esophageal Carcinoma, Hypopharyngeal Carcinoma
Phase 2TerminatedMayo Clinic52014-04-142019-10-01
Aerosolized Aldesleukin in Treating Patients With Lung Metastases
Aerosolized Aldesleukin, Laboratory Biomarker Analysis - Metastatic Malignant Neoplasm in the Lung, Metastatic Melanoma
Phase 1 / Phase 2Active not recruitingM.D. Anderson Cancer Center702012-06-282026-10-15

Showing 20 of 22. Sign in to see all of them.

Narrower conditions

Lung Neoplasms (9)  ·  Carcinoma, Non-Small-Cell Lung (6)  ·  Colorectal Neoplasms (4)  ·  Sarcoma (4)  ·  Osteosarcoma (3)  ·  Breast Neoplasms (2)  ·  Melanoma (2)  ·  Bone Neoplasms (1)  ·  Carcinoma, Renal Cell (1)  ·  Esophageal Neoplasms (1)  ·  Hypopharyngeal Neoplasms (1)  ·  Laryngeal Neoplasms (1)  ·  Lymphatic Metastasis (1)  ·  Lymphoma (1)  ·  Mesothelioma (1)

Broader conditions

Neoplasms (22)  ·  Neoplasms by Site (18)  ·  Lung Diseases (11)  ·  Respiratory Tract Diseases (11)  ·  Respiratory Tract Neoplasms (11)  ·  Thoracic Neoplasms (11)  ·  Neoplasms by Histologic Type (8)  ·  Neoplasms, Connective and Soft Tissue (7)  ·  Bronchial Neoplasms (6)  ·  Carcinoma, Bronchogenic (6)  ·  Digestive System Diseases (5)  ·  Digestive System Neoplasms (5)  ·  Gastrointestinal Diseases (5)  ·  Gastrointestinal Neoplasms (5)  ·  Colonic Diseases (4)

Interventions

Radiosurgery (6)  ·  Magnetic Resonance Spectroscopy (3)  ·  1,2-diaminocyclohexaneplatinum II citrate (2)  ·  Cisplatin (2)  ·  Metastasectomy (2)  ·  Nivolumab (2)  ·  Platinum (2)  ·  Radiation (2)  ·  Specimen Handling (2)  ·  X-Rays (2)  ·  CTLA-4 Antigen (1)  ·  Colony-Stimulating Factors (1)  ·  Congresses as Topic (1)  ·  Continuous Positive Airway Pressure (1)  ·  Cyclophosphamide (1)

Sponsors

M.D. Anderson Cancer Center (6)  ·  Mayo Clinic (3)  ·  National Cancer Institute (NCI) (2)  ·  Northwestern University (2)  ·  Roswell Park Cancer Institute (2)  ·  Stanford University (2)  ·  University of Washington (2)  ·  Children's Oncology Group (1)  ·  Julie L. Sutcliffe, Ph.D (1)  ·  NRG Oncology (1)

Countries

United States (22)  ·  Canada (4)  ·  Puerto Rico (3)  ·  Australia (2)  ·  New Zealand (2)  ·  Saudi Arabia (2)  ·  South Korea (1)

Top investigators

Chukwumere Nwogu (1)  ·  Cristina Rodriguez (1)  ·  David W Rice (1)  ·  Janani S. Reisenauer, M.D. (1)  ·  Jing Zeng (1)  ·  John J Doski (1)  ·  Julianne M Pollard (1)  ·  Julie Sutcliffe (1)  ·  Kenneth Seastedt (1)  ·  Maximilian Diehn (1)  ·  Mohamed E Abazeed (1)  ·  Mohamed E Abazeed, MD, PhD (1)  ·  Najat Daw (1)  ·  Natalie Lui (1)  ·  Osama Mawlawi (1)

Results publications

PMID 35602670, PMID 36669140, PMID 42208702

NIH funding

U10CA180886 (3), P30CA060553 (2), P30CA015083 (1), P30CA015704 (1), P30CA016672 (1), P30CA093373 (1), U10CA098543 (1), U10CA180868 (1)